148 related articles for article (PubMed ID: 18208989)
1. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1).
McFarland R; Hudson G; Taylor RW; Green SH; Hodges S; McKiernan PJ; Chinnery PF; Ramesh V
Arch Dis Child; 2008 Feb; 93(2):151-3. PubMed ID: 18208989
[TBL] [Abstract][Full Text] [Related]
2. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
Hynynen J; Komulainen T; Tukiainen E; Nordin A; Arola J; Kälviäinen R; Jutila L; Röyttä M; Hinttala R; Majamaa K; Mäkisalo H; Uusimaa J
Liver Transpl; 2014 Nov; 20(11):1402-12. PubMed ID: 25065347
[TBL] [Abstract][Full Text] [Related]
3. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase γ (POLG1).
McFarland R; Hudson G; Taylor RW; Green SH; Hodges S; McKiernan PJ; Chinnery PF; Ramesh V
BMJ Case Rep; 2009; 2009():. PubMed ID: 21686371
[TBL] [Abstract][Full Text] [Related]
4. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
[TBL] [Abstract][Full Text] [Related]
5. POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders.
Saneto RP; Lee IC; Koenig MK; Bao X; Weng SW; Naviaux RK; Wong LJ
Seizure; 2010 Apr; 19(3):140-6. PubMed ID: 20138553
[TBL] [Abstract][Full Text] [Related]
6. Drug-resistant epilepsia and fulminant valproate liver toxicity. Alpers-Huttenlocher syndrome in two children confirmed post mortem by identification of p.W748S mutation in POLG gene.
Pronicka E; Weglewska-Jurkiewicz A; Pronicki M; Sykut-Cegielska J; Kowalski P; Pajdowska M; Jankowska I; Kotulska K; Kalicinski P; Jakobkiewicz-Banecka J; Wegrzyn G
Med Sci Monit; 2011 Apr; 17(4):CR203-9. PubMed ID: 21455106
[TBL] [Abstract][Full Text] [Related]
7. Acute liver failure after valproate exposure: Liver transplantation may be indicated beyond childhood.
McKiernan P
Liver Transpl; 2014 Nov; 20(11):1287-9. PubMed ID: 25179873
[No Abstract] [Full Text] [Related]
8. Valproic acid for myoclonic epilepsy in POLG1 carriers can be fatal.
Finsterer J
Folia Neuropathol; 2021; 59(1):17-18. PubMed ID: 33969673
[TBL] [Abstract][Full Text] [Related]
9. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
[TBL] [Abstract][Full Text] [Related]
10. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
Stewart JD; Horvath R; Baruffini E; Ferrero I; Bulst S; Watkins PB; Fontana RJ; Day CP; Chinnery PF
Hepatology; 2010 Nov; 52(5):1791-6. PubMed ID: 21038416
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.
Horvath R; Hudson G; Ferrari G; Fütterer N; Ahola S; Lamantea E; Prokisch H; Lochmüller H; McFarland R; Ramesh V; Klopstock T; Freisinger P; Salvi F; Mayr JA; Santer R; Tesarova M; Zeman J; Udd B; Taylor RW; Turnbull D; Hanna M; Fialho D; Suomalainen A; Zeviani M; Chinnery PF
Brain; 2006 Jul; 129(Pt 7):1674-84. PubMed ID: 16621917
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure.
Delarue A; Paut O; Guys JM; Montfort MF; Lethel V; Roquelaure B; Pellissier JF; Sarles J; Camboulives J
Pediatr Transplant; 2000 Feb; 4(1):67-71. PubMed ID: 10731063
[TBL] [Abstract][Full Text] [Related]
13. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations.
Ashley N; O'Rourke A; Smith C; Adams S; Gowda V; Zeviani M; Brown GK; Fratter C; Poulton J
Hum Mol Genet; 2008 Aug; 17(16):2496-506. PubMed ID: 18487244
[TBL] [Abstract][Full Text] [Related]
14. [Acute hepatic failure associated with valproic acid in children. Report of 3 cases].
Antoniuk SA; Bruck I; Hönnicke LR; Martins LT; Carreiro JE; Cat R
Arq Neuropsiquiatr; 1996 Dec; 54(4):652-4. PubMed ID: 9201347
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA.
Lin CM; Thajeb P
Metab Brain Dis; 2007 Mar; 22(1):105-9. PubMed ID: 17226098
[TBL] [Abstract][Full Text] [Related]
16. Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-gammaA.
Ferrari G; Lamantea E; Donati A; Filosto M; Briem E; Carrara F; Parini R; Simonati A; Santer R; Zeviani M
Brain; 2005 Apr; 128(Pt 4):723-31. PubMed ID: 15689359
[TBL] [Abstract][Full Text] [Related]
17. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
Zsurka G; Baron M; Stewart JD; Kornblum C; Bös M; Sassen R; Taylor RW; Elger CE; Chinnery PF; Kunz WS
J Neuropathol Exp Neurol; 2008 Sep; 67(9):857-66. PubMed ID: 18716558
[TBL] [Abstract][Full Text] [Related]
18. Valproate hepatotoxicity in a 5-year-old boy with cerebral palsy due to neonatal asphyxia.
Kakinuma H; Fujiki T; Nakamura T; Takahashi H
Pediatr Int; 2006 Dec; 48(6):631-3. PubMed ID: 17168987
[No Abstract] [Full Text] [Related]
19. Normal biochemical analysis of the oxidative phosphorylation (OXPHOS) system in a child with POLG mutations: a cautionary note.
de Vries MC; Rodenburg RJ; Morava E; Lammens M; van den Heuvel LP; Korenke GC; Smeitink JA
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S299-302. PubMed ID: 18500570
[TBL] [Abstract][Full Text] [Related]
20. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P
Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
